Many studies have shown that dysregulation of AHR in hepatocytes leads to steatosis and aberrant cholesterol metabolism [10], and increased expression of AHR has been noted in HCC [12], suggesting its potential pro-tumorigenic activity; however, the tumorigenic activity of AHR is still unclear. The gene discussed is AHR; the disease is hepatocellular carcinoma.